LEGN Legend Biotech Corporation ADRs

Legend Biotech is a clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies in hematology/oncology, infectious diseases and auto-immune disorders. Legend operates in the USA, mainland China and Ireland. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$41.00  -0.09 (-0.22%)
As of 10/05/2022 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  
IPO date:  01/02/2015
Outstanding shares:  164,091,842
Average volume:  800,783
Market cap:   $6,609,619,396
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BMX9K07
Valuation   (See tab for details)
PE ratio:   -17.49
PB ratio:   13.45
PS ratio:   73.61
Return on equity:   -81.83%
Net income %:   -429.40%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy